Garber Alan M
SEC CIK 1312907 · EDGAR
BoughtSold
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
| 20 | Garber Alan M | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 16:58 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | Garber Alan M | Dir | A - Grant | $0.00 | +472 | 7,344 | +7% | $0 |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | Garber Alan M | Dir | A - Grant | $0.00 | +398 | 6,872 | +6% | $0 |
| D | 2024-03-25 | 2024-03-21 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | S - Sale+OE | $24.01 | -19.2K | 35.7K | -35% | -$461.1K |
| D | 2024-03-25 | 2024-03-21 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | M - OptEx | $19.57 | +23.5K | 54.9K | +75% | +$459.7K |
| D | 2023-05-03 | 2023-05-01 | VRTX | Vertex Pharmaceuticals | Garber Alan M | Dir | A - Grant | $0.00 | +584 | 6,474 | +10% | $0 |
| D | 2023-02-23 | 2023-02-21 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | S - Sale+OE | $17.49 | -40.0K | 31.4K | -56% | -$699.6K |
| D | 2023-02-23 | 2023-02-21 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | M - OptEx | $6.30 | +40.0K | 71.4K | +127% | +$252.0K |
| D | 2022-03-03 | 2022-03-01 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | M - OptEx | $3.13 | +40.0K | 52.7K | +315% | +$125.2K |
| D | 2022-03-03 | 2022-03-01 | EXEL | EXELIXIS, INC. | Garber Alan M | Dir | S - Sale+OE | $21.00 | -21.3K | 31.4K | -40% | -$447.3K |
Purchase Sale Sale after option exercise All abbreviations